Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03536897 · ClinicalTrials.gov registry record

IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

A clinical trial of Breast Cancer, sponsored by Mount Carmel Health System.

Recruiting
Registry status
168
Enrollment target
1
Study location

NCT03536897 is a study of Breast Cancer that is actively recruiting participants, run by Mount Carmel Health System. The registered enrollment target is 168 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03536897, a study of Breast Cancer, is actively recruiting participants, sponsored by Mount Carmel Health System.

RECRUITING
Registry status
168 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, registry trial which will enroll women aged 65 and above with early stage, low risk breast cancer who will be treated with partial mastectomy and intraoperative radiation therapy (IORT). The primary aim is to determine the 5-year risk of in-breast tumor recurrence. Secondary aims include identification of acute- and late-toxicity, cosmetic result, disease-free survival and overall survival.

Conditions Studied

Interventions

  • RADIATION IORT

Study Locations (1)

Ohio

  • Mount Carmel West Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2018-02-27
Est. Completion 2028-02-27

Sponsor

Mount Carmel Health System

8 total trials

What the Registry Record Tells You About NCT03536897

The ClinicalTrials.gov registry entry for NCT03536897 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Mount Carmel Health System, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT is the first listed.

NCT03536897 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03536897 about?

NCT03536897 is a clinical study titled "IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry". This is a prospective, registry trial which will enroll women aged 65 and above with early stage, low risk breast cancer who will be treated with partial mastectomy and intraoperative radiation therapy (IORT). The primary aim is to determine the 5-year risk of in-breast tumor recurrence. Secondary a...

What is the current status of trial NCT03536897?

This trial is currently recruiting. The enrollment target is 168 participants. The study started on 2018-02-27. Estimated completion is 2028-02-27.

What conditions does trial NCT03536897 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT03536897?

The interventions under investigation include: IORT (RADIATION).

Who is sponsoring clinical trial NCT03536897?

This trial is sponsored by Mount Carmel Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03536897 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.